VivaGel

 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2007-2017
012320072017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Background: Poor pharmacokinetic profiles and resistance are the main two drawbacks from which currently used antiviral agents… (More)
  • figure 1
  • figure 2
  • figure 2
  • figure 5
  • figure 5
Is this relevant?
2015
2015
INTRODUCTION Innate activity against Escherichia coli in female genital secretions may represent contributions from vaginal… (More)
Is this relevant?
2011
2011
UNLABELLED SPL7013 Gel (VivaGel(®)) is a microbicide in development for prevention of HIV and HSV. This clinical study assessed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2011
2011
OBJECTIVES The study was designed to assess the safety, adherence, acceptability, and effect on vaginal microflora of 3% SPL7013… (More)
Is this relevant?
2011
2011
OBJECTIVE To assess the safety of VivaGel® used vaginally twice daily for 14 days among healthy, sexually-abstinent women, aged… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Review
2009
Review
2009
Management of genital herpes is complex. Apart from using the standard antivirals, an ideal management protocol also needs to… (More)
  • figure 1
  • table 1
Is this relevant?
2009
2009
BACKGROUND A dye-based method for determining applicator usage in microbicide trials has been developed to assess whether… (More)
Is this relevant?
2009
2009
SPL7013 is the sodium salt of a sulfonated dendrimer that has potent antiviral properties. VivaGel, a topical gel containing 3… (More)
Is this relevant?
2008
2008
729 Viva VivaGel! Starpharma hopes one of those success stories could be VivaGel (Table 1). This drug is a topical, vaginal… (More)
  • figure 1
Is this relevant?
Review
2007
Review
2007
Microbicides are compounds that applied vaginally or rectally, protect the user from sexually transmitted infections. Although no… (More)
  • table 1
  • table 2
Is this relevant?